Just Other Articles - Internet and Businesses Online

The third thing is email JV's, and by JV's I mean a Joint Venture. This is

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

not something that's easy to do before you have, I realistically want to

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

say that you need a thousand people on your email list. Basically what I d

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

, is I email other people who have lists and I ask them if they're interes

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ted in mailing some type of a free offer to my list, in exchange for me do

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ng the same thing with their's.

What happens is, typically on any given d

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ay, only the most responsive people on my list, the most responsive people

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

on their list will answer that type of a free gift. So what happens if bot

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

h of us are able to build up our lists with more responsive individuals.

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

t is an extremely powerful method. But it is not really something you can

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

do until you've got a good thousand or realistically fifteen hundred subsc

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ribers on your list. Because a lot of people just simply won't swap with y

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

u.

So how do you do it?

Send an email like this to people who have lists

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

:

Hi,

I won’t waste your time here.

I noticed you have a very similar d

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

mographic on your list as I have one mine.

Would you be interested in mai

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ling an offer to my list in exchange for my mailing an offer to your list?

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

Let me know.

Sean

Here is the subject line for that email: Interested

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

in doing an emailing swap?

I typically get about a 25% conversion rate on

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

that email, and end with out 25% of the people to whom I send that email,

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

doing a swap with me.

Are some duds? Sure? Do I do well on others? Yep

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/71208/justotherarticles-List-Building-Using-Email-Joint-Ventures.html">List Building Using Email Joint Ventures</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/71208/justotherarticles-List-Building-Using-Email-Joint-Ventures.html]List Building Using Email Joint Ventures[/url]

The quantity and quality of the idea pool is important. The Economist (2003b) states that 3000 bright ideas are needed for 100 worthwhile projects, which in turn will be winnowed down to four development programmes for new products. And four such development programmes are the minimum needed to stand any chance of getting one winner.

In the recent years the internet has grown a lot in popularity and in size. Almost all the remarkable companies in the world now have a web interface because it is simply not possible for any company to ignore the huge market that can be associated with the online world. This is the biggest advantage...

Tags

Links

Just Other Articles - List Building Using Email Joint Ventures

Related Articles: